Proton Therapy Market is Estimated to USD 2,661.12 Million by the end of 2028: Cognitive Market Research

Market Overview:
Proton Therapy is a proton beam treatment and it is a type of external beam radiation therapy system which uses proton rather than X-rays to provide a treatment to cancer patients. These protons used in the radiation therapy helps to kill cancer cells that destroys healthy cell of body decreasing the immunity of a patient. This treatment is a type of external beam radiation therapy and it painlessly delivers radiation through skin from a machine outside the body.
Proton therapy system comprises of an accelerator or cyclotron, an energy selection system, beam transport system, rotating gantry irradiation equipment includes gantry, irradiation nozzle, patient positioning equipment. This proton therapy system accurately helps to shorten the beam radiation therapy duration and prevent healthy tissue damage and with accuracy it damages the cancerous tumor protecting healthy tissue or cells of patient.
The advantage of proton therapy system, is it gives less radiation dose to the target cell and prevents damage of health tissues as it occurs in X ray radiation. The high-speed proton develops high energy and these protons travels to the desired depth in the body. Proton Therapy is used to treat cancer such as central nervous system cancers, including chordoma, chondrosarcoma, malignant meningioma, eye cancer, including uveal melanoma, choroidal melanoma, head, neck cancer, that includes nasal cavity, paranasal sinus cancer lung, liver cancer, prostate cancer.

Market Insight:
• The Global Proton Therapy Market is valued at USD 764.25 Million in 2016 and is expected to reach USD 2,661.12 Million by the end of 2028, growing at a CAGR of 13.49% between 2021 and 2028.
• The Lung Cancer Revenue (USD Million) is estimated to reach at USD 566.42 Million in 2028
• The Single Room Revenue (USD Million) in Proton Therapy is anticipated to reach USD 1,805.91 Million in 2028.
• The Europe Proton Therapy market size is projected to reach USD 1,027.46 Million in 2028.

To know more The Proton Therapy Market Insight click here: https://www.cognitivemarketresearch.com/proton-therapy-market-report

Market Drivers:
• Increasing prevalence of Cancer:
Cancer is an abnormal growth of cells in the human body. Some of the body cells begin to divide without stopping and spread into surrounding tissues. Cancer cases has been increased by 28% between 2006 and 2016. Cancer prevalence means the number of people in the population who have had a diagnosis of cancer. The incidence of cancer increase has multiple aetiologias.
Cancer is the second leading cause of death globally, and is responsible for about 10 million deaths per year. It is estimated that about 1 in 6 deaths is due to cancer. Major risk factors for cancer are tobacco use, alcohol use, change in lifestyle, unhealthy diet, physical inactivity and air pollution. All these factors have increased the prevalence of cancer among world's population. Moreover, some chronic diseases are risk factors for cancer especially in low- and middle-income countries. Approximately 13% of cancers diagnosed in 2018 globally were attributed to carcinogenic infections, including Helicobacter pylori, human papillomavirus (HPV), hepatitis B virus, hepatitis C virus, and Epstein-Barr virus.
• Rise in geriatric population:
Population ageing is an increasing median age in a population and a shift of region's population towards older ages due to various reasons. Mostly developed countries are facing increasing number of older population due to rising life expectancy. An increase in longevity raises the average age of the population by increasing the numbers of surviving older people. Declining fertility is one of the major reasons in increasing geriatric population. Due to this, numbers of younger people are reducing. It has been estimated that rate of population ageing is likely to increase over the next three decades giving rise to increase in the geriatric population.
According to the data provided by WHO, by 2050, the world's population aged 60 years and older is expected to total 2 billion, up from 900 million in 2015. Today, 125 million people are aged 80 years or older. According to the data published by UN, the global population aged 60 years or over numbered 962 million in 2017, more than twice as large as in 1980 when there were 382 million older persons worldwide. By 2050, there will be almost this many (120 million) living in China alone, and 434 million people in this age group worldwide. By 2050, 80% of all older people will live in low- and middle-income countries.
• Rise in geriatric population:
Restraints for Proton Therapy Market
Lack of trained professionals
• Opportunities for Proton Therapy Market
Rising Healthcare Expenditure

Market Segmentation:
Application
• Lung Cancer
Lung cancer is commonly diagnosed cancer and cause of deaths are reported due to lung cancer. The lung cancer of early stage, non-small-lung cancer is effectively treated by proton radiation therapy and it has potential benefits associated with the treatment. The benefits of using proton therapy system or external beam radiation are that it decreases the dose to the heart and uninfected lungs. The commercial proton therapy system used to treat lung cancer with effective and accurate treatment using spot and li e scanning technique. This system with-it high-power proton beam therapy destroy the infected lungs through radiation given by system and ensure precision and safety in the treatment of patient.
• Gastro-intestinal Cancer
The proton therapy system used in gastro-intestinal cancer treatment, the system gives high dose of proton radiation delivered directly to target tissue or cancerous cells, preventing healthy cells from damage. and vital organs such as liver, kidneys, small bowel and stomach. The gastrointestinal tumors with proton therapy system have benefits, as it protects the vital organs and tissue from radiation. The reduced proton radiation dose by system leads to lesser side effects to patient than Xray radiation treatment. The different types of gastro-intestinal cancer such as esophageal, anal cancers, liver cancer has been treated by the proton beam system with efficacy and accurate treatment. The system deposits high power protons at target area of tumor for shorter period improves the efficacy and reduced side-effects to cancer cells. The proton beam radiation therapy system is proven primary choice of treatment for esophageal cancer. The primary liver cancer treated with proton therapy system, as some patients having cancer are affected earlier with liver cirrhosis and other complication which compels healthcare professionals to use safe, effective treatment. Hence there is increasing demand for proton radiation system to treat cancer of liver with safety, accuracy.Head and Neck Cancer
• Pediatric Cancer
• Sarcoma
• Prostate Cancer
• Brain Cancer
• Others

End-user
• Single Room
These are also called single-gantry proton machines. The patient receives a proton therapy in a special treatment room. The healthcare professional takes the patient to these room, enable the patient to take the correct position in order to target only the cancerous cell and leaves the room and operate the machine room outside monitoring the process through a video placed inside the treatment room. Single room models have only one gantry, hence can treat only one patient at a time. These machines are much more affordable and hence used in private and small hospitals.
• Multiple Room
It is also known as Multi-gantry systems which used one large cyclotron to generate the beam which is delivered to several different rooms at a time, facilitating treatments of multiple patients during the course of a treatment cycle. In some center multiple room are simultaneously used for the treatment of multiple patients at a time which are placed in different rooms. In this case the protons are magnetically steered from one room to the next which are ready at nearly the same time to deliver
the proton treatment to the person in each room. These types of machine are available at high cost and are installed in large hospitals and universities.

Get free sample pages of latest published Proton Therapy Market Report: https://www.cognitivemarketresearch.com/proton-therapy-market-report/report_enquiry/4

Competitive Analysis for Proton Therapy Market:
IBA, Varian Technologies, Hitachi, Mitsubishi Electric, SHI Group, Sumitomo Heavy Industries, ProTom International, Mevion, ProNova, Optivus Proton Therapy

Varian Medical System Inc.
Varian Medical System Inc. has developed and built innovative cancer care technologies, radiotherapy, and providing solutions for the clinical partners. Company has adopted innovation in design of the radiation systems for cancer treatment. Varian Medical System Inc. has combined power and technology to achieve growth in the market against cancer disease. The company operates under two segments such as oncology segments and proton solutions in the market. The various advanced and innovative treatment options for cancer disease radiation therapy are radiosurgery, radiotherapy, proton therapy, which has ProBeam 360 degree, ProBeam, treatment planning for this system, brachytherapy, adaptive therapy, interventional solutions, software's.

NEWS
• September 2020
Varian Company has Introduced Next-Evolution Treatment Planning with Eclipse
The company has announced that it has received FDA approval for upgradation for its Eclipse treatment planning software for proton therapy.
• October 2019
Varian ProBeam System was selected by the Ohio University for New Proton Therapy Center
Varian company has announced that it was selected by the Ohio State University to equip a new multi room proton therapy center with ProBeam 360 system.

Related Report:
Proton Therapy Equipment Market: https://www.cognitivemarketresearch.com/proton-therapy-equipment-market-report
Proton Therapy Solution Market: https://www.cognitivemarketresearch.com/proton-therapy-solution-market-report
Proton Therapy Instrument Market: https://www.cognitivemarketresearch.com/proton-therapy-instrument-market-report

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Nicolas Shaw
Cognitive Market Research
20 N State Street,Chicago,
Illinois, 60602
United States
USA: +1 312-376-8303
Europe and UK: (+44) 20-8144-9523
Asia Pacific: (+852) 81930785
Email: sales@cognitivemarketresearch.com
Website: https://www.cognitivemarketresearch.com/about-us

About Cognitive Market Research:
Cognitive Market Research has evolved as one leading market research and consulting firm and it provides services across multiple domains. Cognitive Market Research gathers and analyzes data about customers, competitors, distributors, and other market actors and forces operational across the value chain. As a market research company, we follow a complete process of gathering information about the target market and end-use industries to verify the complete journey of the product or service in the global market. It helps our readers understand the demand and viability of their product/service and how it might perform in the real world and help them to build business strategies accordingly.

This release was published on openPR.